Literature DB >> 3094064

Dopamine autoreceptors in the ventral tegmental area show subsensitivity following withdrawal from chronic antidepressant drug treatment.

A Towell, P Willner, R Muscat.   

Abstract

The suppression by apomorphine of food intake and eating time was used to assay the sensitivity of dopamine cell body autoreceptors during the course of treatment with DMI, amitriptyline and mianserin. Brief (2-4 days) DMI treatment enhanced the effects of apomorphine, administered systemically or centrally to DA cell body regions. During chronic DMI treatment (3-7 weeks) some evidence of autoreceptor subsensitivity was observed with systemic apomorphine, but not with central apomorphine. Responses to apomorphine applied systemically were reduced during withdrawal from chronic DMI, and responses to apomorphine applied to the ventral tegmental area were reduced during withdrawal from all three antidepressants. As evidence of DA autoreceptor subsensitivity was only observed reliably during withdrawal, this effect is unlikely to be of clinical importance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3094064     DOI: 10.1007/bf00172873

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

1.  Drug-induced syndromes in rats with large, chronic lesions in the corpus striatum.

Authors:  I Divac
Journal:  Psychopharmacologia       Date:  1972

2.  Potentiation by desipramine of the pressor and depressor effects of dopamine.

Authors:  K Kadzielawa; M Popielarski
Journal:  J Pharm Pharmacol       Date:  1971-07       Impact factor: 3.765

3.  The effect of tricyclic antidepressants on apomorphine-induced hypothermia in the mouse.

Authors:  J Maj; L Pawlowski; G Wiszniowska
Journal:  Pol J Pharmacol Pharm       Date:  1974 May-Jun

4.  Apomorphine anorexia: a behavioural and neuropharmacological analysis.

Authors:  P Willner; A Towell; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

5.  Apomorphine anorexia: a further pharmacological characterization.

Authors:  R Muscat; P Willner; A Towell
Journal:  Eur J Pharmacol       Date:  1986-04-09       Impact factor: 4.432

6.  Subacute apomorphine injections in rats: effects on components of behavioral stereotypy.

Authors:  D Gordon; C H Beck
Journal:  Behav Neural Biol       Date:  1984-07

7.  Failure of apomorphine to induce dopamine receptor hypersensitivity.

Authors:  A Flemenbaum
Journal:  Psychopharmacology (Berl)       Date:  1979-04-11       Impact factor: 4.530

8.  Antagonism of hypothermia and behavioral response to apomorphine: a simple, rapid and discriminating test for screening antidepressants and neuroleptics.

Authors:  A J Puech; R Chermat; M Poncelet; L Doaré; P Simon
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

9.  Electroconvulsive treatment and haloperidol: effects on pre- and postsynaptic dopamine receptors in rat brain.

Authors:  A Reches; H R Wagner; A I Barkai; V Jackson; E Yablonskaya-Alter; S Fahn
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 10.  Dopamine and depression: a review of recent evidence. III. The effects of antidepressant treatments.

Authors:  P Willner
Journal:  Brain Res       Date:  1983-12       Impact factor: 3.252

View more
  3 in total

1.  Apomorphine anorexia: the role of dopamine receptors in the ventral forebrain.

Authors:  A Towell; P Willner; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

2.  Voltammetric evidence that subsensitivity to reward following chronic mild stress is associated with increased release of mesolimbic dopamine.

Authors:  J A Stamford; R Muscat; J J O'Connor; J Patel; S J Trout; W J Wieczorek; Z L Kruk; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Changes in dopamine autoreceptor sensitivity in an animal model of depression.

Authors:  R Muscat; A Towell; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.